Have trouble sleeping? Here’s how to snooze soundly.
Experts point out ways you can solve bad habits, insomnia and other problems that keep you from getting decent shut-eye. View original article Contributor: Michele Lent Hirsch
Month: April 2022
Who Ended the Travel Mask Mandate? A Vaccine Skeptic, a Judge, and 2 Others
The mask rule on planes and public transportation has been targeted by the travel industry and Republican lawmakers. In the end, it was brought down by a little-known nonprofit, a conservative judge and chance. View original article Contributor: Heather Murphy and Charlie Savage
Sticking it out: Acupuncture helps Veteran beat addiction – VAntage Point – VAntage Point Blog
Sticking it out: Acupuncture helps Veteran beat addiction – VAntage Point VAntage Point Blog >View original article Contributor:
Mounting Evidence Backs Massage Therapy’s Reduction in Postoperative Pain – Pain Medicine News
Mounting Evidence Backs Massage Therapy’s Reduction in Postoperative Pain Pain Medicine News >View original article Contributor:
Solving one of the biggest challenges in healthcare – MedTech Dive
Solving one of the biggest challenges in healthcare MedTech Dive >View original article Contributor:
Recall Alert: Pfizer recalls blood pressure medicine – News 12 Bronx
Recall Alert: Pfizer recalls blood pressure medicine News 12 Bronx >View original article Contributor:
Traditional Medicine Practice Role in Management of Malaria | IDR – Dove Medical Press
Traditional Medicine Practice Role in Management of Malaria | IDR Dove Medical Press >View original article Contributor:
Some Ohio Republicans Want Law Promoting ‘Alternative’ COVID Treatments – Newsweek
Some Ohio Republicans Want Law Promoting ‘Alternative’ COVID Treatments Newsweek >View original article Contributor:
Rayont Inc Announces changes to its Board of Directors to strengthen its Corporate Governance … – The Bakersfield Californian
Rayont Inc Announces changes to its Board of Directors to strengthen its Corporate Governance … The Bakersfield Californian >View original article Contributor:
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA – Endpoints News
After 18 years in development, AstraZeneca’s CTLA-4 antibody gets the red carpet treatment at the FDA Endpoints News >View original article Contributor: